Live Research Database
Migraine
Hub: Amherst, NY
Connecting patients in Amherst with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in New York
Available Migraine Opportunities
13 RecruitingNCT07018713(Verify)
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
RECRUITING
Migraine
NCT04743141(Verify)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RECRUITING
Migraine
NCT05711394(Verify)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
RECRUITING
Migraine
NCT05125302(Verify)
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RECRUITING
Migraine
NCT04649242(Verify)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RECRUITING
Migraine
NCT07018700(Verify)
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
RECRUITING
Migraine
NCT05164172(Verify)
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
RECRUITING
Migraine
NCT06810505(Verify)
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
RECRUITING
Migraine
NCT06543914(Verify)
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
RECRUITING
Migraine
NCT05156398(Verify)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
RECRUITING
Migraine
NCT04965675(Verify)
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
RECRUITING
Migraine
NCT06417775(Verify)
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
RECRUITING
Migraine
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Migraine research in Amherst through safe, transparent, and patient-first clinical trials."
Migraine Hubs in NY
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT